arrow
S

Stephen B. Ting

monash university
H指数:26
被引数:2,982

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy

低剂量阿糖胞苷和维奈克拉在不符合强化疗条件的急性髓系白血病患者中的风险分层

2025-11-240
OAAI
Cellular and Cell-Free Genomic Characterization of Patients Receiving Avatrombopag and Immunosuppressive Therapy for Treatment-Naïve Severe Aplastic Anemia

接受Avatrombopag和免疫抑制疗法治疗初治重型再生障碍性贫血患者的细胞及无细胞基因组特征

BLOOD
IF23.1
2024-11-050
PRE
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts
LEUKEMIA
IF13.4
2024-01-233
PRE
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (vol 11, 171, 2021)
2021-10-261
OAAI
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150)
2021-10-0122
OAAI